Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Bendamustine in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Ujjani C, Cheson BD.

Expert Rev Anticancer Ther. 2010 Sep;10(9):1353-65. doi: 10.1586/era.10.116. Review.

PMID:
20836669
2.

Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Elefante A, Czuczman MS.

Am J Health Syst Pharm. 2010 May 1;67(9):713-23. doi: 10.2146/ajhp090328. Review.

PMID:
20410545
3.

Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.

Dennie TW, Kolesar JM.

Clin Ther. 2009;31 Pt 2:2290-311. doi: 10.1016/j.clinthera.2009.11.031. Review.

PMID:
20110042
4.

Bendamustine therapy in chronic lymphocytic leukemia.

Masiello D, Tulpule A.

Expert Opin Pharmacother. 2009 Jul;10(10):1687-98. doi: 10.1517/14656560903032698. Review.

PMID:
19527193
5.

Bendamustine in the treatment of chronic lymphocytic leukemia.

Knauf W.

Expert Rev Anticancer Ther. 2009 Feb;9(2):165-74. doi: 10.1586/14737140.9.2.165. Review.

PMID:
19192955
6.

Bendamustine: a new treatment option for chronic lymphocytic leukemia.

Glode AE, Jarkowski A.

Pharmacotherapy. 2009 Nov;29(11):1375-84. doi: 10.1592/phco.29.11.1375. Review.

PMID:
19857152
7.

Bendamustine (Treanda) for CLL and NHL.

[No authors listed]

Med Lett Drugs Ther. 2008 Nov 17;50(1299):91-2. No abstract available. Erratum in: Med Lett Drugs Ther. 2008 Dec 1;50(1300):96.

PMID:
19008789
8.
9.

Bendamustine: new perspective for an old drug in lymphoproliferative disorders.

Montillo M, Ricci F, Tedeschi A, Vismara E, Morra E.

Expert Rev Hematol. 2010 Apr;3(2):131-48. doi: 10.1586/ehm.10.7. Review.

PMID:
21083456
10.

Bendamustine: rebirth of an old drug.

Cheson BD, Rummel MJ.

J Clin Oncol. 2009 Mar 20;27(9):1492-501. doi: 10.1200/JCO.2008.18.7252. Epub 2009 Feb 17. Review. Erratum in: J Clin Oncol. 2009 Jun 10;27(17):2892.

PMID:
19224851
11.

Drug essentials. An alkylating agent for CLL and NHL.

Wilkes GM.

Oncology (Williston Park). 2009 Apr;23(4 Suppl Nurse Ed):55-6. No abstract available.

PMID:
19856600
12.

Bendamustine: inadequate or outdated data.

[No authors listed]

Prescrire Int. 2012 Mar;21(125):64.

PMID:
22428184
13.

Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial.

Ujjani C, Cheson B.

Future Oncol. 2011 Jan;7(1):9-14. doi: 10.2217/fon.10.169.

PMID:
21174533
14.

Bendamustine: a novel cytotoxic agent for hematologic malignancies.

Blumel S, Goodrich A, Martin C, Dang NH.

Clin J Oncol Nurs. 2008 Oct;12(5):799-806. doi: 10.1188/08.CJON.799-806.

PMID:
18842536
15.

Bendamustine: rescue of an effective antineoplastic agent from the mid-twentieth century.

Leoni LM.

Semin Hematol. 2011 Apr;48 Suppl 1:S4-11. doi: 10.1053/j.seminhematol.2011.03.002. Review.

PMID:
21530771
16.

Bendamustine: a review of its use in the management of indolent non-Hodgkin lymphoma.

Plosker GL, Carter NJ.

Drugs. 2008;68(18):2645-60. doi: 10.2165/0003495-200868180-00009. Review.

PMID:
19093705
17.

In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.

Chow KU, Boehrer S, Geduldig K, Krapohl A, Hoelzer D, Mitrou PS, Weidmann E.

Haematologica. 2001 May;86(5):485-93.

18.

Bendamustine's emerging role in the management of lymphoid malignancies.

Rummel MJ, Gregory SA.

Semin Hematol. 2011 Apr;48 Suppl 1:S24-36. doi: 10.1053/j.seminhematol.2011.03.004. Review.

PMID:
21530769
19.

Bendamustine.

Balfour JA, Goa KL.

Drugs. 2001;61(5):631-8; discussion 639-40. Review.

PMID:
11368287
20.

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.

Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A.

Leuk Res. 2012 Jun;36(6):709-14. doi: 10.1016/j.leukres.2011.10.024. Epub 2011 Dec 7.

PMID:
22154023
Items per page

Supplemental Content

Write to the Help Desk